Latest filing published 18 Jan 2008 for Cascadian Therapeutics, Inc., €5,510.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Edward A. Taylor: trading record in brief
Edward A. Taylor is a declared insider of Cascadian Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 10 December 2007 to 18 January 2008, the count stands at 3 filings.
Every open-market trade on record is a purchase: 1 purchase worth €5,510, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2008: 1 purchase and no sales on the market.
The latest filing, published on 18 January 2008, reports an open-market purchase of €5,510 in Cascadian Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward A. Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,450 shares@ US$1.81Common StockSEC:0001179110-08-001414:0Canonical exit: 17 Apr 2008 (T+90)
- 341 sharesCommon StockSEC:0001179110-07-023297:1
- 6,566 sharesCommon StockSEC:0001179110-07-023297:0
3 of 3 declarations